Table 1.
Shortlist of the 35 selected molecules and their documented pharmacological classes.
| Name | Pharmacological class |
|---|---|
| Adiphenine | Parasympatholytics/Anticholinergics/Antispamodics |
| Alpha-estradiol* | 5 alpha-reductase inhibitors/Androgenic alopecia treatment |
| Amiloride*# | Epithelial Sodium Channel Blockers/Diuretics/Acid Sensing Ion Channel Blockers |
| Apigenin*# | Anti-Inflammatory Agents, Non- steroidal/? |
| Benzathine benzylpenicillin# | Anti-Bacterial Agents |
| Biperiden* | Antiparkinson Agents/Muscarinic Antagonists/Parasympatholytics |
| Carmustine | Antineoplastic Agents, Alkylating |
| Chloropyramine | Histamine H1 Antagonists |
| Clofilium tosylate | Anti-Arrhythmia Agents |
| Diltiazem | Antihypertensive Agents/Calcium Channel Blockers/Cardiovascular Agents/Vasodilator Agents |
| Diphenhydramine | Anesthetics, Local/Anti-Allergic Agents/Antiemetics/Histamine H1 Antagonists/Hypnotics and Sedatives |
| Etilefrine | Adrenergic beta-1 and alpha agonist/Cardiotonic/antihypotensive agent. |
| Felbinac# | Anti-Inflammatory Agents, Non-steroidal |
| Flucytosine*# | Antifungal Agents/Antimetabolites |
| Folic acid | Hematinics/Vitamin B Complex |
| Fusidic acid# | Anti-Bacterial Agents/Protein Synthesis Inhibitors |
| Genistein | Anticarcinogenic Agents/Phytoestrogens/Protein Kinase Inhibitors |
| Gentamicin# | Anti-Bacterial Agents/Protein Synthesis Inhibitors |
| Lanatoside C | Anti-Arrhythmia Agents |
| Levamisole* | Adjuvants, Immunologic/Antinematodal Agents/Antirheumatic Agents |
| Methoxamine | Adrenergic alpha-1 Receptor Agonists/Sympathomimetics/Vasoconstrictor Agents |
| Monensin*# | Antifungal Agents/Antiprotozoal Agents/Coccidiostats/Proton Ionophores/Sodium Ionophores |
| Nimesulide*# | Anti-Inflammatory Agents, Non-steroidal/Cyclooxygenase Inhibitors |
| Pindolol | Adrenergic beta-Antagonists/Antihypertensive Agents/Serotonin Antagonists/Vasodilator Agents |
| Prednisone# | Anti-Inflammatory Agents/Antineoplastic Agents, Hormonal/Glucocorticoids |
| Prestwick-1103# | Anti-Inflammatory Agents, Non-steroidal/Cyclooxygenase Inhibitors |
| Ranitidine | Anti-Ulcer Agents/Histamine H2 Antagonists |
| Ribavirin* | Antimetabolites/Antiviral Agents |
| Riboflavin* | Photosensitizing Agents/Vitamin B Complex |
| Roxithromycin# | Anti-Bacterial Agents |
| Sulfadimethoxine# | Anti-Infective Agents |
| Sulfamonomethoxine# | Anti-Infective Agents |
| Timolol* | Adrenergic beta-Antagonists/Anti-Arrhythmia Agents/Antihypertensive Agents |
| Tolazoline | Adrenergic alpha-Antagonists/Antihypertensive Agents/Vasodilator Agents |
| Ursodeoxycholic acid | Cholagogues and Choleretics |
Shortlist of the 35 selected candidates representative of the 110 molecules obtained from the in silico screening (Figure 1 and Figure S1). Documented pharmacological classes were obtained from PubChem (https://pubchem.ncbi.nlm.nih.gov). (
*
) indicate molecules previously evaluated for their antiviral properties according to the literature, and numerals (
#
) those belonging to anti-microbial or anti-inflammatory related pharmacological classes.